🤖Artificial Intelligence
Mind-altering substances are (still) falling short in clinical trials
This week I want to look at where we are with psychedelics, the mind-altering substances that have somehow made the leap from counterculture to major focus of clinical research. Compounds like psilocybin—which is found in magic mushrooms—are being explored for all sorts of health applications, inclu
⚡Key InsightsAI analyzing…
J
Jessica Hamzelou
📡
Original Source
MIT Technology Review
https://www.technologyreview.com/2026/03/20/1134419/psychedelics-overhyped-psilocybin-depression-placebo/Tags:#ai#mit-technology-review
Found this useful? Share it!
Read the Full Story
Continue reading on MIT Technology Review
Related Stories
🤖
🤖Artificial Intelligence
OpenAI alums have been quietly investing from a new, potentially $100M fund
1 day ago
🤖
🤖Artificial Intelligence
Google quietly launched an AI dictation app that works offline
2 days ago
🤖
🤖Artificial Intelligence
Iran threatens ‘Stargate’ AI data centers
2 days ago
🤖
🤖Artificial Intelligence
The one piece of data that could actually shed light on your job and AI
2 days ago